- 80154-34-3Benzaldehyde, 4-(b-D-allopyranosyloxy)-
- 80155-01-74H-1-Benzopyran-4-one, 2,3-dihydro-8-hydroxy-5,6,7-trimethoxy-2-phenyl-
- 80155-52-8Zirconium, dichloro(h5-2,4-cyclopentadien-1-yl)[(1,2,3,3a,7a-h)-1H-inden-1-yl]-
- 8015-64-3Oils, angelica
- 8015-65-4Oils, amyris
- 8015-66-5Angelica Oil
- 8015-73-4Oils, basil
- 8015-80-3Fats and Glyceridicoils, kukui nut oil
- 8015-86-9Carnauba wax
- 8015-88-1Oils, carrot
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
N-Methylmitomycin C |
EINECS | N/A |
| CAS No. | 801-52-5 | Density | 1.52g/cm3 |
| PSA | 127.96000 | LogP | -0.03260 |
| Solubility | N/A | Melting Point |
201.25°C (rough estimate) |
| Formula | C16H20 N4 O5 | Boiling Point | 560.9°C at 760 mmHg |
| Molecular Weight | 348.359 | Flash Point | 293°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by ingestion, intravenous, subcutaneous, and intraperitoneal routes. Human systemic effects by intravenous route: blood effects. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione,6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-1,5-dimethyl-,carbamate (ester) (8CI); Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione,6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-1,5-dimethyl-,[1aS-(1aa,8b,8aa,8ba)]-; ENT 50825; Methyl mitomycinC; Methylmitomycin; N-Methylmitomycin C; NCI 56410; NSC 56410; Porfiromycin;Porfiromycine; Regamycin; U 14743 |
Article Data | 7 |
N-Methylmitomycin C Chemical Properties
Product Name: N-Methylmitomycin C
Synonyms of N-Methylmitomycin C (CAS NO.801-52-5) : (1aR-(1aa,8b,8aa,8ba))-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-1,5-dimethylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione ; [(1aS,8S,8aR,8bS)-6-Amino-8a-methoxy-1,5-dimethyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate ; Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-1,5-dimethyl-, (1aS,8S,8aR,8bS)-
InChI: InChI=1/C16H20N4O5/c1-6-10(17)13(22)9-7(5-25-15(18)23)16(24-3)14-8(19(14)2)4-20(16)11(9)12(6)21/h7-8,14H,4-5,17H2,1-3H3,(H2,18,23)/t7-,8+,14+,16-,19?/m1/s1
CAS NO: 801-52-5
Molecular Formula:C16H20N4O5
Molecular Weight :348.3538
Molecular Structure :.png)
Index of Refraction: 1.672
Surface Tension: 74.4 dyne/cm
Density: 1.52 g/cm3
Flash Point: 293 °C
Enthalpy of Vaporization: 84.35 kJ/mol
Boiling Point: 560.9 °C at 760 mmHg
Vapour Pressure: 1.31E-12 mmHg at 25°C
N-Methylmitomycin C Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LDLo | oral | 10mg/kg (10mg/kg) | BEHAVIORAL: FOOD INTAKE (ANIMAL) BLOOD: GRANULOCYTOPENIA | Antibiotics and Chemotherapy Vol. 11, Pg. 445, 1961. |
| human | TDLo | intravenous | 1500ug/kg (1.5mg/kg) | BLOOD: LEUKOPENIA BLOOD: THROMBOCYTOPENIA | Cancer Chemotherapy Reports, Part 1. Vol. 56, Pg. 615, 1972. |
| monkey | LD | oral | > 10mg/kg (10mg/kg) | BLOOD: GRANULOCYTOPENIA | Antibiotics and Chemotherapy Vol. 11, Pg. 445, 1961. |
| mouse | LD50 | intraperitoneal | 44mg/kg (44mg/kg) | Cancer Chemotherapy Reports. Vol. 30, Pg. 9, 1963. | |
| mouse | LD50 | intravenous | 55mg/kg (55mg/kg) | Journal of Medicinal Chemistry. Vol. 14, Pg. 103, 1971. | |
| mouse | LD50 | oral | 88660ug/kg (88.66mg/kg) | National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986, | |
| mouse | LD50 | subcutaneous | 53500ug/kg (53.5mg/kg) | National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986, | |
| rat | LD50 | oral | 68mg/kg (68mg/kg) | "Compounds Available for Fundamental Research, Volume II-6, Antibiotics, A Program of Upjohn Company Research Laboratory." Vol. 2(6), Pg. -, 1971. |
N-Methylmitomycin C Safety Profile
N-Methylmitomycin C (CAS NO.801-52-5) is poisonous by ingestion, intravenous, subcutaneous, and intraperitoneal routes. Human systemic effects by intravenous route: blood effects. Human mutation data reported. When N-Methylmitomycin C (CAS NO.801-52-5) is heated to decomposition, it emits toxic fumes of NOx.
What can I do for you?
Get Best Price
